We are live on ! Find out more
TIL icon

Instil Bio
TIL

98 hedge funds and large institutions have $551M invested in Instil Bio in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 7

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

26% more funds holding

Funds holding: 78 → 98 (+20)

0.04% more ownership

Funds ownership: 4.57% → 4.61% (+0.04%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

57% less capital invested

Capital invested by funds: $1.27B → $551M (-$717M)

Holders
98
Holders Change
+20
Holders Change %
+25.64%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
29
Increased
32
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$19.8M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$8.93M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.87M
4
BlackRock
BlackRock
New York
+$5.94M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.51M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$25.6M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$21M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.28M
4
VA
VR Adviser
New York
-$6.14M
5
NIP
Nicholas Investment Partners
California
-$2.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.08M +$323K +2,283 +24%
Charles Schwab
27
Charles Schwab
California
$1.05M +$131K +926 +9%
UBS AM
28
UBS AM
Illinois
$933K -$56.2K -397 -4%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$902K -$165K -1,168 -11%
AllianceBernstein
30
AllianceBernstein
Tennessee
$901K -$21M -147,965 -94%
Morgan Stanley
31
Morgan Stanley
New York
$645K +$765K +5,401 +341%
VIA
32
Vident Investment Advisory
Georgia
$644K +$496K +3,505 +101%
Two Sigma Investments
33
Two Sigma Investments
New York
$563K +$863K +6,091 New
M&T Bank
34
M&T Bank
New York
$468K +$605K +4,269 +540%
LFCM
35
Long Focus Capital Management
Puerto Rico
$462K +$708K +5,000 New
QF
36
QVT Financial
New York
$456K – – –
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$456K +$257K +1,817 +58%
PM
38
Parametrica Management
Hong Kong
$402K +$620K +4,376 New
CSS
39
Cubist Systematic Strategies
Connecticut
$361K +$554K +3,911 New
AA
40
ALPS Advisors
Colorado
$354K -$397K -2,801 -42%
Voloridge Investment Management
41
Voloridge Investment Management
Florida
$350K +$537K +3,793 New
GCM
42
Graham Capital Management
Connecticut
$319K +$490K +3,461 New
HWAM
43
Hennion & Walsh Asset Management
New Jersey
$303K +$465K +3,280 New
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$297K +$195K +1,375 +75%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$256K +$393K +2,773 New
OQS
46
Occudo Quantitative Strategies
Florida
$202K +$310K +2,187 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$195K -$411K -2,902 -58%
TI
48
Trexquant Investment
Connecticut
$177K +$271K +1,914 New
Deutsche Bank
49
Deutsche Bank
Germany
$152K +$18.8K +133 +9%
AIG
50
American International Group
New York
$150K +$40.6K +287 +21%
1
2
3 4 5

TIL Hedge Fund Activity: Q2 2022 in Review

98 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2022, worth a combined $551M — down 57% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TIL positions and 7 closed out — a net gain of 22 holders — while 32 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, adding an estimated $19.8M. The largest seller was HHLR Advisors, exiting entirely with an estimated $25.6M sold.

  • 98 institutional investors held Instil Bio (TIL) as of Q2 2022, up from 78 in Q1 2022.
  • Funds reported $551M of Instil Bio stock for Q2 2022, down 57% quarter-over-quarter.
  • 29 funds opened new Instil Bio positions in Q2 2022 and 7 closed out, a net change of +22 holders.
  • The largest Instil Bio buyer in Q2 2022 was RA Capital Management, an estimated $19.8M added.
  • The largest Instil Bio seller in Q2 2022 was HHLR Advisors, an estimated $25.6M sold.

Based on aggregated 13F filings for Q2 2022.